Inhibitory effects of chlorogenic acid on aldose reductase activity in vitro and cataractogenesis in galactose-fed rats

Arch Pharm Res. 2011 May;34(5):847-52. doi: 10.1007/s12272-011-0519-z. Epub 2011 Jun 9.

Abstract

Chlorogenic acid (5-O-caffeoylquinic acid, CA), a phenolic compound found ubiquitously in plants, has antidiabetic effect in diabetic animal models. In this study, we investigated the inhibitory effect of CA on diabetic cataractogenesis. We evaluated the aldose reductase (AR) activity during cataract development in 50% galactose-fed rats, an animal model of sugar cataract. Galactose-fed rats were treated orally with CA (10 and 50 mg/kg body weight) once a day for 2 weeks. In vehicle-treated galactose-fed rats, lens opacity was increased, and lens fiber swelling and membrane rupture were observed. In addition, AR protein was highly expressed in lens epithelial cells and lens cortical fibers of galactose-fed rats. However, CA inhibited the rat AR activity in vitro, and the administration of CA prevented the development of sugar cataract through the inhibition of AR activity. These observations suggest that CA is useful for the treatment of sugar cataract.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aldehyde Reductase / metabolism*
  • Animals
  • Cataract / chemically induced
  • Cataract / enzymology
  • Cataract / pathology
  • Cataract / prevention & control*
  • Cell Membrane / drug effects
  • Cell Membrane / ultrastructure
  • Chlorogenic Acid / analogs & derivatives*
  • Chlorogenic Acid / pharmacology
  • Chlorogenic Acid / therapeutic use
  • Diabetes Complications / chemically induced
  • Diabetes Complications / enzymology
  • Diabetes Complications / pathology
  • Diabetes Complications / prevention & control*
  • Dose-Response Relationship, Drug
  • Enzyme Inhibitors / pharmacology
  • Enzyme Inhibitors / therapeutic use
  • Epithelial Cells / drug effects
  • Epithelial Cells / enzymology
  • Epithelial Cells / ultrastructure
  • Eye Proteins / metabolism
  • Galactose / administration & dosage
  • Galactose / toxicity*
  • Hypoglycemic Agents / pharmacology
  • Hypoglycemic Agents / therapeutic use*
  • Immunohistochemistry
  • Lens Cortex, Crystalline / drug effects
  • Lens Cortex, Crystalline / enzymology
  • Lens Cortex, Crystalline / ultrastructure
  • Lens, Crystalline / drug effects*
  • Lens, Crystalline / enzymology
  • Lens, Crystalline / ultrastructure
  • Male
  • Microscopy, Fluorescence
  • Quinic Acid / analogs & derivatives*
  • Quinic Acid / pharmacology
  • Quinic Acid / therapeutic use
  • Random Allocation
  • Rats
  • Rats, Sprague-Dawley

Substances

  • Enzyme Inhibitors
  • Eye Proteins
  • Hypoglycemic Agents
  • Quinic Acid
  • Chlorogenic Acid
  • Aldehyde Reductase
  • 5'-O-caffeoylquinic acid
  • Galactose